Hyperion Pharma Co Private Limited
About Hyperion Pharma Co Private Limited
Data last updated:
Hyperion Pharma Co Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 16 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2014PTC202557. Its GSTIN is 19AADCH4462P1Z0 (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jiwan Agarwala and Sajan Kumar Agarwal.
Its last annual general meeting (AGM) was held on 28 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Sbm Arcade First Floor Shop No – I Sevoke Road, Siliguri, West Bengal, India – 734001.
As per the financials filed for FY 2020, the company reported a revenue of ₹19.63 Lakh, a growth of 42% compared to the previous year. For the same year it recorded a net loss of ₹12.16 Lakh (net margin -61.9%) and EBITDA of -₹12.15 Lakh (EBITDA margin -61.9%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hyperion Pharma Co Private Limited's registered office is in Siliguri, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSbm Arcade First Floor Shop No – I Sevoke Road, Siliguri, West Bengal, India – 734001
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Hyperion Pharma Co Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hyperion Pharma Co is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hyperion Pharma Co Private Limited, buy the company report.
Financials of Hyperion Pharma Co Private Limited
FY 2020 filings availableHyperion Pharma Co Private Limited reported revenue of ₹19.63 Lakh (up 42% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 42% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 7%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -61.9% | ||||
| Net Profit Margin | -61.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hyperion Pharma Co Private Limited, buy the company report.
Board of directors of Hyperion Pharma Co Private Limited
Hyperion Pharma Co has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jiwan Agarwala | Director | 10 Nov 2014 | 12 Years 0 Months | Current |
| Sajan Kumar Agarwal | Director | 16 Jul 2014 | 12 Years 3 Months | Current |
| Nitu Garg Agarwal | Director | 16 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Hyperion Pharma Co Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alrosa Pharmaceuticals Private Limited | ₹19.64 Lakh (FY 2025) | -26.0% | Ambala, Haryana, India | |||
| Gaytnam Ventures India Private Limited | ₹19.64 Lakh (FY 2023) | 145.0% | Sahibabad, Uttar Pradesh, India | |||
| Ahana Energy Limited | ₹19.64 Lakh (FY 2019) | 51383.0% | Nagpur, Maharashtra, India | |||
| Suryachakra Thermal (Madhya Pradesh) Private Limited | ₹19.64 Lakh (FY 2025) | -6.0% | Hyderabad, Telangana, India | |||
| SMPT Village Development Initiative Private Limited | ₹19.63 Lakh (FY 2025) | Sikandrabad, Uttar Pradesh, India | ||||
| Hyperion Pharma Co Private Limitedthis company | ₹19.63 Lakh (FY 2020) | -₹12.16 Lakh | -61.9% | 42.0% | Siliguri, West Bengal, India | |
| Big Crunch Multi-Solutions (OPC) Private Limited | ₹19.63 Lakh (FY 2025) | 4.0% | New Delhi, Delhi, India | |||
| Oswal Worsted Spinners Limited | ₹19.63 Lakh (FY 2019) | 71.0% | Ludhiana, Punjab, India | |||
| Scotlin Pharmaceuticals Private Limited. | ₹19.63 Lakh (FY 2025) | 5.0% | Delhi, India | |||
| Home Comfort India Private Limited | ₹19.63 Lakh (FY 2024) | -85.0% | Amritsar, Punjab, India | |||
| Dombe Patil Foods Private Limited | ₹19.63 Lakh (FY 2025) | 9.0% | Pune, Maharashtra, India |
To see the full peer comparison of Hyperion Pharma Co Private Limited, buy the company report.
Auditor
Hyperion Pharma Co Private Limited is audited by ARCB & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARCB & ASSOCIATES | FY 2017 | 327773E |
Shareholding
The shareholding of Hyperion Pharma Co Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hyperion Pharma Co Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hyperion Pharma Co Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hyperion Pharma Co Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hyperion Pharma Co has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCH4462P1Z0 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hyperion Pharma Co Private Limited, buy the company report.
Recent activity
Hyperion Pharma Co Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Jiwan Agarwala was appointed as Director on 10 Nov 2014.
Frequently asked questions
Hyperion Pharma Co is an active private limited company based in Siliguri, West Bengal, India. The company works in wholesale, within the trading industry. It was incorporated on 16 July 2014 (12+ years old) and is registered under CIN U74900WB2014PTC202557.
Hyperion Pharma Co has 3 current directors:
- Jiwan Agarwala - Director
- Sajan Kumar Agarwal - Director
- Nitu Garg Agarwal - Director
The latest financial statements of Hyperion Pharma Co on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 28 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Hyperion Pharma Co is 19AADCH4462P1Z0, registered in West Bengal.
The CIN (Corporate Identification Number) of Hyperion Pharma Co is U74900WB2014PTC202557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hyperion Pharma Co was incorporated on 16 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Hyperion Pharma Co by revenue are Alrosa Pharmaceuticals Private Limited, Gaytnam Ventures India Private Limited, Ahana Energy Limited, Suryachakra Thermal (Madhya Pradesh) Private Limited, SMPT Village Development Initiative Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Jiwan Agarwala was appointed as Director on 10 Nov 2014. Nitu Garg Agarwal was appointed as Director on 16 Jul 2014. Sajan Kumar Agarwal was appointed as Director on 16 Jul 2014.
The registered office of Hyperion Pharma Co is at Sbm Arcade First Floor Shop No – I Sevoke Road, Siliguri, West Bengal, India – 734001.
Hyperion Pharma Co operates in the trading industry, in the wholesale segment.
The compliance status of Hyperion Pharma Co is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
